Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research: Implementing the patient-driven research paradigm to aid decision making in stroke care - 18/06/15
, Emily C. O’Brien, PhD a, Gregg C. Fonarow, MD b, DaiWai M. Olson, RN, PhD c, Lee H. Schwamm, MD d, Deidre Hannah, RN, MSN e, Brianna Lindholm, BA e, Lesley Maisch, BA e, Barbara L. Lytle, MS a, Melissa A. Greiner, MS a, Jingjing Wu, MS a, Eric D. Peterson, MD, MPH a, Michael J. Pencina, PhD a, Adrian F. Hernandez, MD, MHS aRésumé |
Background |
Stroke is common and costly, annually depriving the lives and well-being of 800,000 Americans. Despite demonstrated efficacy in clinical trials, questions remain about the safety and clinical effectiveness of various treatment options given patient characteristics, conditions, preferences, and their desired outcomes.
Methods and results |
The Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) is a Patient-Centered Outcomes Research Institute–sponsored project designed to help patients, physicians, and other stakeholders make informed decisions regarding stroke care and improve outcomes through patient-centered comparative effectiveness research. The primary outcomes identified and prioritized by stroke patients are “home time” (time spent alive and outside a hospital) and major adverse cardiovascular events. With inputs from stroke patients themselves, a series of comparative safety and effectiveness analyses will be performed across 3 prioritized therapeutic areas identified as important by stroke survivors: oral anticoagulants, statin therapy, and antidepressants. We obtained data from Get With the Guidelines-Stroke linked with Medicare claims and follow-up telephone interviews. Our combined retrospective and prospective research strategy allows the evaluation of the safety and effectiveness of various treatment options and patient-centered longitudinal outcomes. To ensure the rapid translation of findings into clinical practice, results will be disseminated to stroke survivors, caregivers, and health care providers through traditional and social media, including an online decision aid tool.
Conclusions |
PROSPER is a patient-centered outcome research study guided by patients, caregivers, and the broader health care community. By addressing knowledge gaps in treatment uncertainties through comparative effectiveness research, PROSPER has the potential to improve decision making in stroke care and patient outcomes reflecting individual patient preferences, needs, and values.
Le texte complet de cet article est disponible en PDF.Plan
| Clinical trial registration: ClinicalTrials.gov NCT02146274. |
|
| Sources of funding: This work was supported by an award (CE-1304) from the Patient-Centered Outcomes Research Institute. |
Vol 170 - N° 1
P. 36 - juillet 2015 Retour au numéro
Article précédent
- Considerations for assessing the potential effects of antidiabetes drugs on cardiac ventricular repolarization: A report from the Cardiac Safety Research Consortium
- Simon Heller, Börje Darpö, Malcolm I. Mitchell, Helle Linnebjerg, Derek J. Leishman, Nitin Mehrotra, Hao Zhu, John Koerner, Mónica L. Fiszman, Suchitra Balakrishnan, Shen Xiao, Thomas G. Todaro, Ingrid Hensley, Brian D. Guth, Eric L. Michelson, Philip Sager
- Statin Recapture Therapy before Coronary Artery Bypass Grafting Trial: Rationale and study design of a multicenter, randomized, double-blinded controlled clinical trial
- Oliver J. Liakopoulos, Elmar W. Kuhn, Martin Hellmich, Kathrin Kuhr, Petra Krause, Hannes Reuter, Meike Thurat, Yeong-Hoon Choi, Thorsten Wahlers, StaRT-CABG Investigators
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?